<DOC>
	<DOCNO>NCT00028288</DOCNO>
	<brief_summary>The purpose study evaluate investigational medication treat chronic persistent asthma . The research conduct 22 clinical research sit US open men woman age 18 70 year old . Participants study number visit research site 10-month period . All study-related care medication provide qualified participant cost : include visit , examination laboratory work .</brief_summary>
	<brief_title>Study Daclizumab Patients With Chronic , Persistent Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Daclizumab</mesh_term>
	<mesh_term>Immunoglobulin G</mesh_term>
	<criteria>History asthma 6 month History chronic persistent asthma require daily high dose inhale corticosteroid 3 month prior enrollment Patients 10 pack year smoke history smoking within 12 month study enrollment No significant disease asthma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Daclizumab</keyword>
	<keyword>anti-Tac monoclonal antibody</keyword>
	<keyword>anti-IL-2</keyword>
	<keyword>Zenapax</keyword>
</DOC>